Current Good Manufacturing Practice Production of an Oncolytic Recombinant Vesicular Stomatitis Viral Vector for Cancer Treatment-Reference-Cited by-同舟云学术

Current Good Manufacturing Practice Production of an Oncolytic Recombinant Vesicular Stomatitis Viral Vector for Cancer Treatment

Published:2011-04 Issue:4 Volume:22 Page:489-497
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Ausubel L.J.¹,Meseck M.²,Derecho I.¹,Lopez P.¹,Knoblauch C.¹,McMahon R.¹,Anderson J.¹,Dunphy N.¹,Quezada V.¹,Khan R.¹,Huang P.¹,Dang W.¹,Luo M.¹,Hsu D.¹,Woo S.L.C.²,Couture L.¹

Affiliation:

1. Center for Biomedicine and Genetics, and Center for Applied Technology Development, Beckman Research Institute of City of Hope, Duarte, CA 91010.

2. Department of Gene and Cell Medicine, Mount Sinai School of Medicine, New York, NY 10029.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2010.159

Reference39 articles.

1. Replicative adenoviruses for cancer therapy

2. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

3. An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

4. Human Infection with the Virus of Vesicular Stomatitis during an Epizootic

5. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a new vaccine at the laboratory scale;Bioreactor Design Concepts for Viral Vaccine Production;2024

2. The use of viral vectors in vaccine development;npj Vaccines;2022-07-04

3. Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate;Vaccine;2021-11

4. Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography;BioTech;2021-10-12

5. Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies;Journal of Hematology & Oncology;2021-04-16